Safety and Tolerability of FMT Capsules in Healthy Volunteers

Summary

This is a two-part, randomized, double-blind, placebo-controlled, single center study to investigate the safety and tolerability of XBI-302 administered orally in healthy volunteers. The hypothesis of this study is that XBI-302 is safe and well tolerated with the proposed dosing regimens.

Timeline

Start

2022-04-21

Primary completion

2022-08

Completion

2022-10

Drugs

Indications